|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The proliferation markers Ki-67/MIB-l,phosphohistone H3,and survivin may contribute in the identification of aggressive ovarian carcinomas显示文摘 | Aune G Stunes AK Tingulstad S | 2011 | Int J Clin Exp Pathol2011，4，5： | 1 |
| 2 | The proliferation markers Ki-67/MIB-1 ,phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas显示文摘 | Aune G Stunes AK Tingulstad S | 2011 | Int J Clin Exp Patho12011，4，5： | 1 |
| 3 | Skeletal effects of the saturated 3-Thia fatty acid tetradecylthioacetic acid in rats显示文摘 | Stunes AK Syversen U | 2011 | PPAR Res2011，2011，1： | 1 |
| 4 | The proliferation markers Ki-67/MIB-l,phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas 显示文摘 | Aune G Stunes AK Tingulstad S | 2011 | Irtt J Clin Exp Patho12011，4，5： | 1 |
| 5 | The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas显示文摘 | Aune G Stunes AK Tingulstad S | 2011 | Int J Clin Exp Pathol2011，4，5： | 1 |
| 6 | Different skeletal effects of the peroxisome proliferator activated receptor( PPAR )(x agonist fenofibrate and the PPAR~/ agonist pioglitazone 显示文摘 | Syversen U Stunes AK Gustafsson BI | 2009 | BMC Endocr Disord2009，9，6： | 1 |
| 7 | Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism 显示文摘 | Thommesen L Stunes A K Monjo M | 2006 | J Cell Biochem2006，99，3： | 1 |
| 8 | Expression and regulation of resistin in osteoblasts and osteoelasts indicate a role in bone metabolism 显示文摘 | Tbommesen L Stunes AK Monjo M | 2006 | J Cell Biochem2006，99，3： | 1 |
| 9 | The proliferation markers Ki-67/MIB-1, phosphohistone H3,and survivin may contribute in the identification of aggressive ovarian carcinomas显示文摘 | Aune G Stunes A K Tingulstad S | 2011 | Int J Clin Exp Pathol2011，4，5： | 1 |
| 10 | Expression andregulation of resistin in osteoblasts and osteoclasts indicate arole in bone metabolism显示文摘 | Thommesen L Stunes AK Monjo M | 2006 | J CellBioc hem2006，99，3： | 1 |
| 11 | Maximal Strength Training in Postmenopausal Women With Osteoporosis or Osteopenia显示文摘 | Mats P. Mosti Nils Kaehler Astrid K. Stunes Jan Hoff Unni Syversen | 2013 | Journal of Strength and Conditioning Research2013，，10： | 1 |
| 12 | The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas 显示文摘 | Aune G Stunes A K Tingulstad S | 2011 | Int J Clin Exp Pathol2011，4，5： | 1 |
| 13 | Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism显示文摘 | Thommesen L Stunes AK Monjo M | 2006 | J Cell Biochem2006，99，3： | 1 |
| 14 | Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice 显示文摘 | Fossmark R Stunes AK Petzold C | 2012 | J Cell Biochem2012，113，1： | 1 |
| 15 | The proliferation markers Ki-67/MIB-1 ,phosphohistone H3,and survivin may contribute in the identification of aggressive ovarian carcinomas 显示文摘 | Aune G Stunes AK Tingulstad S | 2011 | Int J Clin Exp Pathol2011，4，5： | 1 |
| 16 | Serotonin and flu-oxetine modulate bone cell function in vitro 显示文摘 | Gustafsson BI Thommesen L Stunes AK | 2006 | J Cell Biochem2006，98，： | 1 |
| 17 | The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas 显示文摘 | Aune G Stunes A K Tingulstad S | 2011 | Int J Clin Exp Pathol2011，4，5： | 1 |
| 18 | The per- oxisome proliferator-activated receptor (PPAR) alpha ago- nist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovari- ectomized rats显示文摘 | Stunes AK Westbroek I Gustafsson BI | 2011 | BMC Endocr Disord2011，11，： | 1 |
| 19 | Different skeletal effects of the peroxisome prolifrator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone显示文摘 | Syversen U Stunes AK Gustafsson BI | 2009 | BMC Endocr Disord2009，9，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员